Information Library

White Papers - Get to market faster

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • A Blueprint for Clinical/Commercial Convergence

    August 5, 2010
    The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities.

  • The New Health

    May 26, 2010
    Quintiles examines the complex challenges and opportunities facing the bio pharmaceutical industry and how companies must manage risk, demonstrate greater value and improve patient outcomes.

  • FDA Requirements for Clinical Studies in Pediatric Patients

    April 1, 2010
    FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

  • Data-Driven Patient Recruitment

    March 23, 2010
    Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials.

  • Regulations for Clinical Studies in Pediatric Patients in the European Union

    March 10, 2010
    After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric

  • New FDA Guidance on Antidiabetic Therapies

    December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

  • Chasing Influenza

    November 30, 2009
    The rise in influenza strains like H1N1 — and the demand for new vaccines — signals a new era in vaccines. Learn how flu vaccines have evolved and where they’re headed.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences